• Login
    • Login
    Advanced Search
    View Item 
    •   AMREF IR Home
    • Research Papers
    • General - GEN
    • General - GEN
    • View Item
    •   AMREF IR Home
    • Research Papers
    • General - GEN
    • General - GEN
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Socio-economic Determinants of Disease Progression among HIV Infected Adults in Kenya

    Thumbnail
    View/Open
    Research article (672.8Kb)
    Publication Date
    7/31/2015
    Authors
    Gitahi–Kamau, Nyawira T.
    Kiarie, James N.
    Mutai, Kenneth K.
    Gatumia, Beatrice W.
    Gatongi, P. M.
    Lakati, A.
    Show More
    (6 total)
    Type
    Article, Journal
    Item Usage Stats
    5
    views
    1
    downloads
    Metadata
    Show full item record
    Citation

    Gitahi–Kamau, N.T., Kiarie, J.N., Mutai, K.K. et al. Socio-economic determinants of disease progression among HIV infected adults in Kenya. BMC Public Health 15, 733 (2015). https://doi.org/10.1186/s12889-015-2084-8

    Abstract/Overview

    Background: Socioeconomic determinants have been shown to have an effect on the progression of HIV disease evidenced by studies carried out largely in developed countries. Knowledge of these factors could inform on prioritization of populations during scale up of highly active antiretroviral therapy (HAART) constrained health systems. The objective of this study was to identify socioeconomic correlates of HIV disease progression in an adult Kenyan population. Methods: We analysed data from 312 HIV positive individuals, drawn from a cohort enrolled in a randomized clinical trial investigating the effectiveness of Acyclovir in the prevention of HIV transmission among serodiscordant couples. In this study we included individuals with CD4 counts ≥ 350 cells/mm3 and World Health Organization (WHO), clinical stage one or two. The exposure variables measured were: - daily household income available for expenditure, age, gender, housing type and level of formal education. We used a composite outcome of disease progression to WHO clinical stage 3 or 4 or a laboratory outcome of CD4 count below 350 cells/mm3 after two years of follow-up. Logistic regression was used to determine associations of variables that were found to be significant at univariate analysis, and to control for potential confounders. Results: Seventy eight (25 %) individuals reported HIV disease progression. Majority (79.9 %) were female. The median age was 30 year and 93.6 % had attained a primary level of education. Median CD4 at enrolment into the clinical trial was 564 cells/mm3 ; those who had disease progression were enrolled with a significantly (p < 0.001) lower CD4 count. Daily household income available for expenditure adjusted for CD4 count at enrolment was associated significantly (p = 0.04) with HIV disease progression. Disease progression was five times more likely to occur in study subjects with daily income available for expenditure of less than US$1 compared to those with more than US$ 5 available for daily expenditure [adjusted Odds Ratio 4.6 (95 % Confidence Interval 1.4–14.4)]. Disease progression was not associated with age, gender, type of housing or level of education attained (p < 0.05). Conclusion: Populations with low household incomes should be considered vulnerable to disease progression and should therefore be prioritized during the scale up of HAART for treatment as prevention.

    Subject/Keywords
    Discordant; Highly active antiretroviral therapy; Income; Socio-economic determinants; Disease progression
    Further Details

    © 2015 Gitahi-Kamau et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated

    Publisher
    BioMed Central
    Permalink
    http://repository.amref.org/handle/123456789/150
    Collections
    • General - GEN [355]

    Amref International University. All rights reserved | Copyright © 2021 
    Contact Us | Send Feedback

     

     

    Quick Links
    Amref International UniversityAmref Health AfricaKLISC

    Browse

    All of AMREF IRCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypeThis CollectionBy Issue DateAuthorsTitlesSubjectsType

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Amref International University. All rights reserved | Copyright © 2021 
    Contact Us | Send Feedback